XML 124 R5.htm IDEA: XBRL DOCUMENT v3.25.3
CONDENSED CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' DEFICIT (UNAUDITED) - USD ($)
shares in Thousands, $ in Thousands
Total
Previously Reported [Member]
Redeemable Convertible Preferred Stock [Member]
Redeemable Convertible Preferred Stock [Member]
Previously Reported [Member]
Redeemable Convertible Preferred Stock [Member]
Series A Preferred Stock [Member]
Common Stock [Member]
Common Stock [Member]
Previously Reported [Member]
Additional Paid-in Capital [Member]
Additional Paid-in Capital [Member]
Previously Reported [Member]
Accumulated Deficit [Member]
Accumulated Deficit [Member]
Previously Reported [Member]
Accumulated Comprehensive Income (Loss) [Member]
Share outstanding, beginning balance (in shares) at Dec. 31, 2022     93,963     86,360            
Shareholder's equity, beginning balance at Dec. 31, 2022 $ (135,128)   $ 170,648         $ 6,602   $ (141,740)   $ 10
Issuance of common stock upon exercise of stock options 306         $ 862   306        
Other comprehensive loss (10)                     $ (10)
Stock-based compensation 5,399             5,399        
Correction of an immaterial error of redeemable convertible preferred stock warrants (720)             (720)        
Net loss $ (56,945)                 (56,945)    
Share outstanding, ending balance (in shares) at Dec. 31, 2023 87,222   62,240 93,963   57,776 87,222          
Shareholder's equity, ending balance at Dec. 31, 2023 $ (187,098) $ (187,098) $ 170,648 $ 170,648   $ 6 $ 0 11,581 $ 11,587 (198,685) $ (198,685)  
Reverse recapitalization Share     (31,723)     (29,446)            
Reverse recapitalization           $ 6   (6)        
Issuance of common stock upon exercise of stock options 13         $ 21   13        
Stock-based compensation 1,122             1,122        
Net loss (17,998)                 (17,998)    
Share outstanding, ending balance (in shares) at Mar. 31, 2024     62,240     57,797            
Shareholder's equity, ending balance at Mar. 31, 2024 $ (203,961)   $ 170,648     $ 6   12,716   (216,683)    
Share outstanding, beginning balance (in shares) at Dec. 31, 2023 87,222   62,240 93,963   57,776 87,222          
Shareholder's equity, beginning balance at Dec. 31, 2023 $ (187,098) (187,098) $ 170,648 $ 170,648   $ 6 $ 0 11,581 11,587 (198,685) (198,685)  
Net loss $ (55,107)                      
Share outstanding, ending balance (in shares) at Sep. 30, 2024 6,250,000   62,240     57,855            
Shareholder's equity, ending balance at Sep. 30, 2024 $ (238,172)   $ 170,648     $ 6   15,614   (253,792)    
Share outstanding, beginning balance (in shares) at Dec. 31, 2023 87,222   62,240 93,963   57,776 87,222          
Shareholder's equity, beginning balance at Dec. 31, 2023 $ (187,098) $ (187,098) $ 170,648 $ 170,648   $ 6 $ 0 11,581 11,587 (198,685) (198,685)  
Issuance of common stock upon exercise of stock options 172         $ 424   172        
Stock-based compensation 5,550             5,550        
Net loss $ (69,459)                 (69,459)    
Share outstanding, ending balance (in shares) at Dec. 31, 2024 58,057 87,646 62,240 93,963   58,057 87,646          
Shareholder's equity, ending balance at Dec. 31, 2024 $ (250,835) $ (250,835) $ 170,648 $ 170,648   $ 6   17,303 17,309 (268,144) (268,144)  
Share outstanding, beginning balance (in shares) at Mar. 31, 2024     62,240     57,797            
Shareholder's equity, beginning balance at Mar. 31, 2024 (203,961)   $ 170,648     $ 6   12,716   (216,683)    
Issuance of common stock upon exercise of stock options 10         $ 15   10        
Stock-based compensation 1,149             1,149        
Net loss (17,965)                 (17,965)    
Share outstanding, ending balance (in shares) at Jun. 30, 2024     62,240     57,812            
Shareholder's equity, ending balance at Jun. 30, 2024 (220,767)   $ 170,648     $ 6   13,875   (234,648)    
Issuance of common stock upon exercise of stock options 21         $ 43   21        
Stock-based compensation 1,718             1,718        
Net loss $ (19,144)                 (19,144)    
Share outstanding, ending balance (in shares) at Sep. 30, 2024 6,250,000   62,240     57,855            
Shareholder's equity, ending balance at Sep. 30, 2024 $ (238,172)   $ 170,648     $ 6   15,614   (253,792)    
Share outstanding, beginning balance (in shares) at Dec. 31, 2024 58,057 87,646 62,240 93,963   58,057 87,646          
Shareholder's equity, beginning balance at Dec. 31, 2024 $ (250,835) $ (250,835) $ 170,648 $ 170,648   $ 6   17,303 17,309 (268,144) (268,144)  
Reverse recapitalization Share     (31,723)     (29,589)            
Reverse recapitalization           $ 6   (6)        
Issuance of common stock upon exercise of common stock warrants           17            
Issuance of common stock upon exercise of stock options 508         $ 942   508        
Stock-based compensation 1,878             1,878        
Net loss (128,185)                 (128,185)    
Share outstanding, ending balance (in shares) at Mar. 31, 2025     62,240     59,016            
Shareholder's equity, ending balance at Mar. 31, 2025 $ (376,634)   $ 170,648     $ 6   19,689   (396,329)    
Share outstanding, beginning balance (in shares) at Dec. 31, 2024 58,057 87,646 62,240 93,963   58,057 87,646          
Shareholder's equity, beginning balance at Dec. 31, 2024 $ (250,835) $ (250,835) $ 170,648 $ 170,648   $ 6   17,303 $ 17,309 (268,144) $ (268,144)  
Net loss $ (511,846)                      
Share outstanding, ending balance (in shares) at Sep. 30, 2025 174,957   142     174,957            
Shareholder's equity, ending balance at Sep. 30, 2025 $ (219,503)   $ 223,185     $ 17   560,470   (779,990)    
Share outstanding, beginning balance (in shares) at Mar. 31, 2025     62,240     59,016            
Shareholder's equity, beginning balance at Mar. 31, 2025 (376,634)   $ 170,648     $ 6   19,689   (396,329)    
Issuance of common stock upon exercise of stock options 428         $ 726   428        
Stock-based compensation 3,013             3,013        
Net loss (113,726)                 (113,726)    
Share outstanding, ending balance (in shares) at Jun. 30, 2025     62,240     59,742            
Shareholder's equity, ending balance at Jun. 30, 2025 (486,919)   $ 170,648     $ 6   23,130   (510,055)    
Issuance of common stock upon exercise of common stock warrants         142              
Series A redeemable convertible preferred stock issued in connection with reverse recapitalization, net         $ 223,185              
Issuance of common stock upon exercise of stock options 285         $ 462   285        
Stock-based compensation 5,245             5,245        
Net loss (269,935)                 (269,935)    
Conversion of redeemable convertible preferred stock in connection with reverse recapitalization (in shares)     (62,240)     62,240            
Conversion of redeemable convertible preferred stock in connection with reverse recapitalization 170,648   $ (170,648)     $ 6   170,642        
Reverse recapitalization transaction, net of transaction costs (in shares)           52,513            
Reverse recapitalization transaction, net of transaction costs $ 361,173         $ 5   361,168        
Share outstanding, ending balance (in shares) at Sep. 30, 2025 174,957   142     174,957            
Shareholder's equity, ending balance at Sep. 30, 2025 $ (219,503)   $ 223,185     $ 17   $ 560,470   $ (779,990)